Trial
NCT00772668
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Lymphoma
Intervention
Rituximab
Why stopped
Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-11